Theraheart
PrivateLast Round
Series A
Oct 22, 2025
Est. Valuation
$35.4M
Total Funding Raised
$20.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Theraheart is a medical device company that manufactures minimally invasive solutions aimed at improving the lives of heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theraheart Comparables
Compare Theraheart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adona Medical | 84% | |
| Puzzle Medical Devices Inc. | 84% | |
| Procyrion | 82% |
Theraheart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 80% MoM, reaching 1K.
- Jul 27, 2026
Monthly visitors increased 753% MoM, from 68 to 580.
Theraheart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Theraheart's valuation, stock price, and market status.
Is Theraheart a public or private company?
Theraheart is a private company.
What is the current stock price of Theraheart?
Theraheart is a private company with no public stock price. Caplight tracks Theraheart's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Theraheart worth (valuation)?
Theraheart's valuation is estimated at $35.4M based on funding round data.
Can I buy Theraheart stock?
Theraheart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Theraheart's last funding round?
Theraheart's most recent funding round was Series A on October 22, 2025.
Who are the main investors in Theraheart?
Investor information for Theraheart is not publicly disclosed.
Will Theraheart IPO soon?
No public IPO plans have been announced for Theraheart.
How can I track Theraheart secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theraheart's secondary market activity and sign up for updates.